Literature DB >> 19211576

Mecillinam: a low-risk antimicrobial agent for induction of Clostridium difficile infection in an in vitro human gut model.

Simon D Baines, Rachael O'Connor, Grace Huscroft, Katie Saxton, Jane Freeman, Mark H Wilcox.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19211576     DOI： 10.1093/jac/dkp017

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  4 in total

Review 1.  Models for the study of Clostridium difficile infection.

Authors:  Emma L Best; Jane Freeman; Mark H Wilcox
Journal:  Gut Microbes       Date:  2012-03-01

2.  Development and validation of a chemostat gut model to study both planktonic and biofilm modes of growth of Clostridium difficile and human microbiota.

Authors:  Grace S Crowther; Caroline H Chilton; Sharie L Todhunter; Scott Nicholson; Jane Freeman; Simon D Baines; Mark H Wilcox
Journal:  PLoS One       Date:  2014-02-06       Impact factor: 3.240

3.  SMT19969 as a treatment for Clostridium difficile infection: an assessment of antimicrobial activity using conventional susceptibility testing and an in vitro gut model.

Authors:  S D Baines; G S Crowther; J Freeman; S Todhunter; R Vickers; M H Wilcox
Journal:  J Antimicrob Chemother       Date:  2014-09-03       Impact factor: 5.790

Review 4.  Antimicrobial Resistance and Reduced Susceptibility in Clostridium difficile: Potential Consequences for Induction, Treatment, and Recurrence of C. difficile Infection.

Authors:  Simon D Baines; Mark H Wilcox
Journal:  Antibiotics (Basel)       Date:  2015-07-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.